Novartis Gene Therapies, Inc.
483 response sent August 23, 2019 · California
- Pages
- 59
- FEI number
- 3014617030
In short: This is Novartis Gene Therapies, Inc.'s written response to FDA, dated August 23, 2019, for its site in California (FEI 3014617030). It sets out the corrective actions the firm committed to.
Inside this response
This inspection in context
Questions about this response
When was Novartis Gene Therapies, Inc. inspected by FDA?
This 483 response is dated August 23, 2019.
How do I get the full 483 response for Novartis Gene Therapies, Inc.?
Download the original PDF from FDA Intel for $199, with no subscription. You also get an invoice PDF with the order.